503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.18%
Net income growth under 50% of ORCL's 25.82%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
5.68%
Some D&A expansion while ORCL is negative at -5.66%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-438.36%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-2.37%
Negative yoy SBC while ORCL is 0.40%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-20.73%
Both reduce yoy usage, with ORCL at -183.83%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-148.90%
Both yoy AR lines negative, with ORCL at -124.93%. Martin Whitman would suspect an overall sector lean approach or softer demand.
217.82%
Some inventory rise while ORCL is negative at -78.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
373.33%
AP growth well above ORCL's 129.05%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
52.40%
Some yoy usage while ORCL is negative at -209.57%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-3.15%
Both negative yoy, with ORCL at -49.18%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-34.86%
Both yoy CFO lines are negative, with ORCL at -91.44%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-49.26%
Negative yoy CapEx while ORCL is 56.28%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
2.31%
Some acquisitions while ORCL is negative at -132.96%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
7.51%
Less growth in investment purchases vs. ORCL's 48.85%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-1.89%
We reduce yoy sales while ORCL is 124.89%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
359.68%
Less 'other investing' outflow yoy vs. ORCL's 1103.36%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
34.31%
Lower net investing outflow yoy vs. ORCL's 155.32%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
93.09%
Debt repayment growth of 93.09% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-46.58%
Negative yoy issuance while ORCL is 16.22%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
22.68%
We have some buyback growth while ORCL is negative at -17.25%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.